Heat Biologics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Heat Biologics's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 28% to $2,112,806. Profit margin reached -1676%. Total operating expenses were $37,531,845.

Profit Margin

Heat Biologics, Inc. (AMEX:HTBX): Profit margin
2012 3.11K -2.42M -77819.94%
2013 0 -8.71M
2014 0 -11.78M
2015 0 -20.29M
2016 341.64K -12.57M -3680.44%
2017 1.51M -11.84M -779.09%
2018 5.79M -15.73M -271.56%
2019 3.04M -20.01M -656.51%
2020 2.94M -26.04M -883.65%
2021 2.11M -35.40M -1675.54%

HTBX Income Statement (2012 – 2021)

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012
Revenue
Revenue
2.11M2.94M3.04M5.79M1.51M341.64K0003.11K
Cost of revenue
0000000000
Gross profit
2.11M2.94M3.04M5.79M1.51M341.64K0003.11K
Operating exp.
Research and development
18.82M12.93M13.01M16.23M8.26M9.33M2.59M2.86M2.73M902.93K
Selling and marketing
0000000000
Total operating expenses
37.53M27.94M22.44M23.25M14.63M13.46M21.02M12.18M6.56M2.34M
Operating income
-35.41M-26.12M-20.74M-17.96M-13.34M-13.12M-21.02M-12.18M-6.56M-2.34M
Other income (expenses), net
-127.74K-257.02K406.26K383.53K123.44K152.52K-100K-56.28K-45.22K-108.34K
Income before tax
-35.54M-26.38M-20.33M-17.57M-13.21M-12.97M-21.12M-12.24M-6.60M-2.45M
Income tax expense
-145.97K-257.02K45.17K-985.48K-809.54K701.92K264K17.07K33.89K0
Net income
-35.40M-26.04M-20.01M-15.73M-11.84M-12.57M-20.29M-11.78M-8.71M-2.42M
Earnings per share
Basic EPS
-1.41-1.63-4.21-6.3-21.56-49.4-174.92-126.18-160.61-90.87
Diluted EPS
-1.41-1.63-4.21-6.3-21.56-49.4-174.92-126.18-160.61-90.87
Data sourceData sourceData sourceData sourceData sourceData sourceData sourceData sourceData source